HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?

Teresa Lopes Ramos(Luxembourg Institute of Health), Fermín Sánchez‐Guijo(Universidad de Salamanca)
Oncotarget
March 7, 2017
Cited by 12


Related Papers